Lpl Financial LLC Pa Vmed Inc. Transaction History

Lpl Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.22 - $0.5 $660 - $1,500	-3,000 Reduced 3.0%	97,159 $29,000
Q2 2023 Jul 31, 2023	BUY	$0.35 - $0.56 $7,962 - $12,740	22,750 Added 29.39%	100,159 $41,000
Q4 2022 Feb 07, 2023	SELL	$0.41 - $1.1 $4,100 - $11,000	-10,000 Reduced 11.44%	77,409 $37,000
Q3 2022 Nov 14, 2022	BUY	$0.57 - $1.77 $21,355 - $66,313	37,465 Added 75.01%	87,409 $75,000
Q2 2022 Aug 12, 2022	BUY	$0.85 - $1.41 $4,003 - $6,641	4,710 Added 10.41%	49,944 $47,000

Q1 2022 May 16, 2022	BUY	$1.16 - $2.5 $16,122 - $34,747	13,899 Added 44.36%	45,234 $60,000
Q4 2021 Feb 14, 2022	BUY	$2.46 - $8.74 $77,084 - $273,867	31,335 New	31,335 $77,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $74.6M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.